Skip to main content


We're creating a new version of this page. See preview

  • Oral presentation
  • Open Access

SpineCor treatment – the Spanish experience. First results

  • 1 and
  • 1
Scoliosis20127 (Suppl 1) :O39

  • Published:


  • Public Health
  • Effective Treatment
  • Adolescent Idiopathic Scoliosis
  • Idiopathic Scoliosis
  • Cobb Angle

Purpose of the study

The purpose of this study was to evaluate the effectiveness of the Dynamic SpineCor brace as a new treatment for adolescent idiopathic scoliosis [1, 2].

Materials and methods

  1. 117

    scoliotic patients at our clinic accepted the SpineCor brace and 34 (30 females and 4 males) have already finished the treatment. Assessment of brace effectiveness included percentage of patients who have 5° or less curve progression and the percentage of patients who have 6° or more progression at skeletal maturity. We employed the SRS22 and CAVIDRA questionnaire for the evaluation of patients’ quality of life while using the SpineCor System.



Success of the treatment (stabilisation or correction) was achieved in 88.3% of patients and only 11.7% had a progression of their Cobb angle. Out of 34 patients, 18 (52.9%) had a correction and 12 (35.3%) had a stabilisation of their initial Cobb.


The SpineCor brace is an effective treatment for the adolescent idiopathic scoliosis. Even though until now we have a small number of patients treated, the results are extremely promising.

Authors’ Affiliations

Centro de Traumatologia y Ortopedia Pediatrica y del Adolescente (CTPA), Girona, Spain


  1. Coillard C, Circo AB, Rivard CH: SpineCor treatment for Juvenile Idiopathic Scoliosis: SOSORT award 2010 winner. Scoliosis. 2010, 5: 25-10.1186/1748-7161-5-25.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Coillard C, Vachon V, Circo A, Beausejour M, Rivard CH: Effectiveness of the SpineCor brace based on the new standardized criteria proposed by the Scoliosis Research Society for Adolescent Idiopathic Scoliosis. J Pediatr Orthop. 2007, 27: 375-379. 10.1097/01.bpb.0000271330.64234.db.View ArticlePubMedGoogle Scholar


© Herrero and Herrero; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.